Join the club for FREE to access the whole archive and other member benefits.

Maria Blasco

Director of Spanish National Cancer Research Centre.

Maria A. Blasco obtained her PhD in 1993 at the Centro de Biología Molecular "Severo Ochoa" under the supervision of M. Salas. That same year, Blasco joined the Cold Spring Harbor Laboratory in New York (USA) as a Postdoctoral Fellow under the leadership of C. W. Greider. As a postdoc she isolated one of the telomerase essential genes and generated the first telomerase deficient mouse model, which served to demonstrate the importance of telomerase in telomere maintenance, chromosomal instability and disease. In 1997, she returned to Spain to start her own research Group at the Centro Nacional de Biotecnología in Madrid. She joined the Spanish National Cancer Research Centre (CNIO) in 2003 as Director of the Molecular Oncology Programme and Leader of the Telomeres and Telomerase Group. In 2005, she was also appointed Vice-Director of Basic Research at CNIO. Since June 2011, she is the CNIO Director.

Visit website:


See also: Institute Spanish National Cancer Research Center (CNIO) - Center for cancer research, including diagnosis and treatments.

Details last updated 07-Nov-2019

Maria Blasco is also referenced in the following:

Longevity Hackers

Feature length documentary about longevity and radical life extension with due to be released in 2023

Longevity Leaders World Congress 2022

26-Feb-2022 to 27-Feb-2022

Event for leaders in longevity science, technology, business and finance organized by Longevity Leaders (LSX)

Longevity Summit Dublin 2022

18-Sep-2022 to 20-Sep-2022

Event gathering Global Longevity and Rejuvenation community in Dublin with many longevity movement superstars as speakers

Maria Blasco News

Rapamycin decreased survival and longevity in mice with short telomeres - 03-Mar-2020

mTOR, a pro-survival pathway for shorter telomeres and inhibition is deleterious


Pluripotency and telomeres, butterfly effect discovered

ScienceDaily - 20-Aug-2019

Pluripotent cells are like a black box, but they can open new doors for regenerative medicine


Telomerase therapy for neurodegeneration (LEAF) - 04-Jun-2019

Telomerase gene therapy may be a potential solution for age-related neurodegenerative diseases


Telomerase Gene Therapy Does Not Increase Cancer Risk (LEAF) - 27-Aug-2018

New research proves telomerase therapy's safety by making its effects within the cell temporary